Atlas Trials

Safety and Efficacy Study of Switching From Epzicom to Truvada

Clinical trial NCT00724711 · COMPLETED

Trial details

NCT number
NCT00724711
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
HIV Infection
Start date
2008-07-01
Primary completion
2011-03-01
Enrollment
312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.